Truist Financial Corp Trims Stock Holdings in Definitive Healthcare Corp. (NASDAQ:DH)

Truist Financial Corp lowered its stake in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 12.3% during the 2nd quarter, HoldingsChannel reports. The fund owned 45,237 shares of the company’s stock after selling 6,368 shares during the period. Truist Financial Corp’s holdings in Definitive Healthcare were worth $247,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also recently made changes to their positions in the stock. Norden Group LLC bought a new stake in shares of Definitive Healthcare during the 1st quarter valued at $83,000. Susquehanna Fundamental Investments LLC bought a new position in Definitive Healthcare in the 1st quarter worth about $120,000. Canada Pension Plan Investment Board bought a new stake in shares of Definitive Healthcare during the second quarter valued at about $109,000. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Definitive Healthcare by 31.4% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 21,292 shares of the company’s stock valued at $116,000 after buying an additional 5,083 shares during the period. Finally, The Manufacturers Life Insurance Company lifted its holdings in shares of Definitive Healthcare by 17.0% in the second quarter. The Manufacturers Life Insurance Company now owns 22,896 shares of the company’s stock worth $125,000 after buying an additional 3,332 shares in the last quarter. 98.67% of the stock is owned by institutional investors.

Definitive Healthcare Price Performance

Shares of Definitive Healthcare stock opened at $4.54 on Friday. The firm has a market capitalization of $535.42 million, a PE ratio of -2.59, a price-to-earnings-growth ratio of 6.27 and a beta of 1.33. The company has a current ratio of 2.40, a quick ratio of 2.40 and a debt-to-equity ratio of 0.27. Definitive Healthcare Corp. has a 12 month low of $3.19 and a 12 month high of $10.62. The business’s 50-day moving average price is $4.36 and its 200-day moving average price is $5.34.

Definitive Healthcare (NASDAQ:DH) last issued its quarterly earnings results on Monday, August 5th. The company reported $0.09 EPS for the quarter, meeting analysts’ consensus estimates of $0.09. The business had revenue of $63.70 million for the quarter, compared to analysts’ expectations of $63.19 million. Definitive Healthcare had a negative net margin of 156.65% and a positive return on equity of 0.98%. The business’s quarterly revenue was up 4.4% on a year-over-year basis. During the same period last year, the business earned $0.08 earnings per share. Sell-side analysts forecast that Definitive Healthcare Corp. will post 0.07 EPS for the current fiscal year.

Analyst Ratings Changes

DH has been the topic of a number of analyst reports. Morgan Stanley decreased their target price on shares of Definitive Healthcare from $9.00 to $5.00 and set an “equal weight” rating on the stock in a report on Tuesday, August 6th. Stifel Nicolaus lowered their price objective on Definitive Healthcare from $9.50 to $7.50 and set a “buy” rating on the stock in a research report on Wednesday, July 31st. Barclays reduced their target price on Definitive Healthcare from $6.00 to $4.00 and set an “equal weight” rating for the company in a research report on Wednesday, August 7th. Robert W. Baird lowered their price target on Definitive Healthcare from $6.00 to $5.00 and set a “neutral” rating on the stock in a report on Wednesday, August 7th. Finally, JPMorgan Chase & Co. lowered Definitive Healthcare from a “neutral” rating to an “underweight” rating and cut their price objective for the stock from $7.00 to $5.00 in a report on Wednesday, July 31st. One research analyst has rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the stock. According to MarketBeat, Definitive Healthcare presently has an average rating of “Hold” and an average target price of $5.81.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.